ZA901630B - Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it - Google Patents
Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing itInfo
- Publication number
- ZA901630B ZA901630B ZA901630A ZA901630A ZA901630B ZA 901630 B ZA901630 B ZA 901630B ZA 901630 A ZA901630 A ZA 901630A ZA 901630 A ZA901630 A ZA 901630A ZA 901630 B ZA901630 B ZA 901630B
- Authority
- ZA
- South Africa
- Prior art keywords
- naphthalenmethanamino
- derivative
- pharmaceutical compositions
- compositions containing
- inflammatory agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
- C07C211/19—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3906720 | 1989-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA901630B true ZA901630B (en) | 1991-11-27 |
Family
ID=6375385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA901630A ZA901630B (en) | 1989-03-03 | 1990-03-02 | Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0385952A2 (xx) |
JP (1) | JPH0334959A (xx) |
KR (1) | KR900014305A (xx) |
AU (1) | AU5060190A (xx) |
CA (1) | CA2011247A1 (xx) |
FI (1) | FI901057A0 (xx) |
HU (1) | HUT58201A (xx) |
IL (1) | IL93590A0 (xx) |
NO (1) | NO900972L (xx) |
PT (1) | PT93306A (xx) |
ZA (1) | ZA901630B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
HU223343B1 (hu) * | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
WO1997008133A1 (en) | 1995-08-22 | 1997-03-06 | Japan Tobacco Inc. | Amide compounds and use of the same |
JP4029960B2 (ja) * | 2001-10-05 | 2008-01-09 | 独立行政法人理化学研究所 | アブシジン酸生合成阻害剤 |
BRPI0418589A (pt) | 2003-12-08 | 2008-01-29 | Bentley Pharmaceuticals Inc | composições farmacêuticas e métodos para tratamento por insulina |
-
1990
- 1990-02-28 HU HU901189A patent/HUT58201A/hu unknown
- 1990-03-01 PT PT93306A patent/PT93306A/pt not_active Application Discontinuation
- 1990-03-01 CA CA002011247A patent/CA2011247A1/en not_active Abandoned
- 1990-03-01 AU AU50601/90A patent/AU5060190A/en not_active Abandoned
- 1990-03-01 IL IL93590A patent/IL93590A0/xx unknown
- 1990-03-01 EP EP90810157A patent/EP0385952A2/en not_active Withdrawn
- 1990-03-01 NO NO90900972A patent/NO900972L/no unknown
- 1990-03-01 FI FI901057A patent/FI901057A0/fi not_active Application Discontinuation
- 1990-03-02 JP JP2052563A patent/JPH0334959A/ja active Pending
- 1990-03-02 KR KR1019900002730A patent/KR900014305A/ko not_active Application Discontinuation
- 1990-03-02 ZA ZA901630A patent/ZA901630B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL93590A0 (en) | 1990-12-23 |
HU901189D0 (en) | 1990-05-28 |
HUT58201A (en) | 1992-02-28 |
KR900014305A (ko) | 1990-10-23 |
CA2011247A1 (en) | 1990-09-03 |
PT93306A (pt) | 1990-11-07 |
AU5060190A (en) | 1990-09-06 |
NO900972L (no) | 1990-09-04 |
EP0385952A2 (en) | 1990-09-05 |
JPH0334959A (ja) | 1991-02-14 |
FI901057A0 (fi) | 1990-03-01 |
NO900972D0 (no) | 1990-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ233320A (en) | 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions | |
NZ238545A (en) | Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof | |
IL103932A0 (en) | Fatty acid derivatives and pharmaceutical compositions containing them | |
HU900583D0 (en) | Lasting dissolving of pharmaceutical compositions | |
IL112558A (en) | Neuroprotective pharmaceutical compositions of 4 phenylpinene derivatives and certain novel 4 phenylpinene compounds | |
IL108019A0 (en) | Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them | |
IL115072A0 (en) | Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use | |
NZ233790A (en) | Benzocycloalkane derivatives and pharmaceutical compositions | |
HU896612D0 (en) | Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof | |
HU896479D0 (en) | Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof | |
IL96747A0 (en) | Oxazole derivatives and pharmaceutical compositions containing them | |
NZ236483A (en) | Glycerol derivatives and pharmaceutical compositions thereof | |
ZA948689B (en) | New taxicin derivatives their preparation and pharmaceutical compositions containing them | |
IL98198A0 (en) | Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide | |
NZ232701A (en) | Substituted benzoxazolinone derivatives and pharmaceutical compositions | |
NZ233013A (en) | Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions | |
ZA901630B (en) | Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it | |
IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
HU895948D0 (en) | Process for the preparation of dipeptidecarbamide derivatives having inhibition of renine and pharmaceutical compositions thereof | |
ZA933426B (en) | New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them | |
HU896636D0 (en) | Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof | |
HU9302821D0 (en) | Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent | |
NZ234803A (en) | Oxazolopyridine derivatives and analgesic pharmaceutical compositions | |
GB9304745D0 (en) | Use of pharmaceutical formulations | |
IL108881A0 (en) | Pharmaceutical compositions containing a combination of verapamil and trandolapril |